Columns

Columns

6th Challenges to "Reverse Value Generation" Drug Discovery
Hiroshi Nagabukuro, Ph.D. (COO/CSO, ARTham Therapeutic/ Adjunct Professor, Oita University, Faculty of Medicine, Department of Clinical Pharmacology & Therapeutics)
5th Small Biotech with a Big Vision
Masaaki Sawa, Ph.D. (Chief Scientific Officer, CARNA BIOSCIENCES, INC.)
4th Coming soon
3rd SEND, FDA, and Industry Movement
Takayuki ANZAI (Professor (AP), Showa University, School of Medicine)
2nd Drug Discovery in Academia – Initiatives by NIBIOHN
Yoshihiro Yoneda (Director General, National Institutes of Biomedical Innovation, Health and Nutrition)
1st Aspiring to be a Navigator of Innovative Drug Discovery Development
Noriatsu KONO (Managing Director, Department of Innovative Drug Discovery and Development, Japan Agency for Medical Research and Development)

Page TOP